In response to the escalating demand for innovative drug classes, the Global Oligonucleotide API Industry is poised for a remarkable surge, with a projected high Compound Annual Growth Rate (CAGR) of 5.60% from 2024 to 2034. According to market analysts, this surge is expected to propel the global oligonucleotide API market from its 2024 valuation …